New syrup aims to soothe coughs in just two days

NCT ID NCT07625683

Not yet recruiting Symptom relief Sponsor: Laboratoires Elerte Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how well and how safely SIROPSEDAL syrup works for acute cough caused by colds or upper respiratory infections. About 124 children and adults will take the syrup as prescribed by their doctor and report their cough severity over one week. The main goal is to see if most people feel a meaningful reduction in cough by the second day.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SIROPSEDAL (a syrup for cough)
What this could lead to: If it works, this could confirm that SIROPSEDAL effectively reduces cough intensity within two days for people with acute cough from colds or respiratory infections.
What could go wrong: This is an observational study without a placebo group, so results may be less reliable. It is also small (124 people) and only follows participants for one week, so long-term effects or comparisons to other treatments are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE COUGH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

common cold Cough respiratory tract infectious disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE COUGH COMMON COLD UPPER RESPIRATORY TRACT INFECTION

Contacts and locations

Locations

Multiples facilities

Multiple Locations, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.